Educational disclaimer. This article is intended for procurement, regulatory affairs, and BMET education. Regulatory environments evolve continuously — verify the current text of FDA 21 CFR Part 807, EU MDR 2017/745, ISO 13485, ISO 10993, AAMI EC12, and your destination market's medical-device regulation directly with the issuing authority before using citations in formal tender or registration documents. Standards revisions, transition deadlines, and certificate renewal timelines change frequently; the information below reflects the regulatory landscape as understood at the time of publication.
TL;DR
For disposable ECG electrodes, "FDA approved" is a phrase that is technically incorrect — Class II devices are cleared, not approved. The compliance pyramid that actually authorizes a manufacturer to market ECG electrodes globally has four layers: (1) Establishment Registration + Device Listing with the FDA (mandatory but not a clearance); (2) 510(k) Clearance under Product Code DRX for U.S. marketing — the actual product authorization; (3) CE Marking under MDR 2017/745 with a Notified Body four-digit number for EU marketing; (4) NMPA registration, MDSAP, and other regional certifications for global reach. Behind these are the performance and safety standards: AAMI EC12 for electrical performance and ISO 10993-5/-10/-23 for biocompatibility. Every claim a supplier makes about regulatory status can be verified in 15–30 minutes through public databases — this guide shows exactly how.
📑 Table of Contents
- Why Compliance Verification Matters More Than the Marketing Claim
- The 4-Layer FDA Compliance Pyramid for ECG Electrodes
- Decoding a 510(k) K-Number and Reading the Summary
- CE Marking Under MDR 2017/745 — Post-Transition Reality
- ISO 13485 Verification: Beyond the Certificate Logo
- AAMI EC12: How to Read the Performance Test Report
- ISO 10993 Biocompatibility for 24–48h Skin Contact
- Sterile vs Non-Sterile: The Regulatory Difference Most Buyers Miss
- 7-Step Verification Protocol (30 Minutes Per Supplier)
- Region-by-Region "Must Have" vs "Nice to Have"
- Frequently Asked Questions
- References & Standards
A U.S. hospital procurement officer received three quotes for disposable ECG electrodes. The price spread was 38% top to bottom. Two suppliers prominently advertised "FDA approved"; one said "FDA registered." The lowest-priced supplier showed a slick certificate that turned out to be an Establishment Registration acknowledgment — not a 510(k) clearance. The hospital almost issued a USD 280,000 PO before the BMET caught the discrepancy in a 15-minute database lookup.
This article is the database-level verification protocol for that lookup. It walks through exactly which FDA, CE, ISO, and AAMI documents prove what — what each phrase means, where to verify it, and what red flags signal a misrepresentation. Compliance for disposable ECG electrodes is not a marketing claim; it is a public-database fact, and it can be verified in 30 minutes per supplier with no specialist training.
📚 This article is part of MedLinket's ECG Electrodes Resource Hub. For the parent overview of structure, materials, and clinical scenarios, start with our ECG Electrodes Complete Buyer's & Clinical Guide. For the broader 12-criteria supplier evaluation framework that places these regulatory checks within a complete supplier scoring model, see How to Evaluate ECG Electrode Suppliers.
Why Compliance Verification Matters More Than the Marketing Claim
Short answer: ECG electrodes are FDA Class II devices in direct skin contact for 24 to 48 hours under occlusion. The combination of skin contact and prolonged wear places them in one of the more stringent regulatory categories among monitoring accessories, with mandatory biocompatibility testing, mandatory electrical-performance characterization, and mandatory pre-market clearance. A supplier that conflates "FDA registered" with "FDA cleared" is at minimum careless and at worst misrepresenting regulatory status — neither is acceptable for a Class II device.
What is at stake
- Patient safety. Inadequately tested adhesive can cause contact dermatitis; inadequately tested gel can cause chemical burns; uncharacterized AC impedance can produce signal artifacts that mimic clinical events and trigger false alarms.
- Customs and import. Non-cleared products are detained at U.S. ports of entry under 21 CFR. EU customs detain Class IIa devices without proper CE marking. Brazil ANVISA and China NMPA enforce equivalent rules.
- Hospital accreditation. The Joint Commission (U.S.), JCI (international), and DNV require traceable supplier documentation as part of regulated supply-chain compliance. Inability to produce the supplier's 510(k) clearance during an accreditation audit is a finding.
- Tort exposure. When a patient develops an electrode-related adverse event, the chain of liability runs from the hospital to the distributor to the manufacturer. Each link must hold its own documentation.
- Recall risk. The FDA maintains a public Medical Device Recall database. A supplier with prior recalls in the same product family is a measurable risk factor regardless of current marketing claims.
The "FDA approved" linguistic trap. Class II devices are cleared through 510(k); only Class III devices receive approval through PMA. The phrase "FDA approved ECG electrodes" is technically incorrect and is often used by suppliers who do not understand — or who deliberately blur — the distinction between FDA establishment registration (a facility listing), FDA device listing (a product identification), and FDA 510(k) clearance (the actual marketing authorization). The remainder of this article uses the precise term: FDA cleared via 510(k) under Product Code DRX.
The 4-Layer FDA Compliance Pyramid for ECG Electrodes
Short answer: The FDA's regulation of disposable ECG electrodes is layered. Each layer has a different legal effect and a different verification method. Conflating the layers — accidentally or deliberately — is the single most common source of misrepresented compliance claims.
Layer 1 — Establishment Registration
Every facility manufacturing, repackaging, or relabeling a medical device for the U.S. market must register annually with the FDA via Form FDA 2891. This produces an FEI (FDA Establishment Identifier) Number. Establishment Registration is mandatory, but it is not a clearance. It does not authorize product marketing; it merely tells the FDA that a facility exists and what it claims to make. The FDA does not pre-inspect or pre-approve registrations.
Verify at: FDA Establishment Registration & Device Listing Database (search by company name or FEI number).
Layer 2 — Device Listing
Each device a registered facility produces is listed on Form FDA 2892, which assigns the device its Product Code. For disposable ECG electrodes, the Product Code is DRX (regulation number 21 CFR 870.2360, "Electrode, Electrocardiograph"). Listing is the second mandatory layer, and like Registration it does not constitute clearance — it tells the FDA which product family the facility intends to make.
Layer 3 — 510(k) Premarket Notification (THE marketing authorization)
Section 510(k) of the U.S. Federal Food, Drug, and Cosmetic Act requires that, before marketing a Class II medical device, the manufacturer demonstrate the device is substantially equivalent to a legally marketed predicate device. Substantial equivalence (SE) is established by comparing intended use, technological characteristics, performance data (including AAMI EC12 testing for ECG electrodes), and biocompatibility (ISO 10993). If the FDA concurs with the SE argument, it issues a K-number clearance (e.g., K252345). Only at this point can the device be legally marketed in the U.S.
The "compatible electrode" subtlety. A supplier marketing electrodes "compatible with Philips" or "compatible with GE" is not exempt from 510(k). The supplier still needs its own 510(k) clearance demonstrating substantial equivalence to a predicate device. Compatibility refers to physical and electrical interface; 510(k) refers to safety and performance equivalence. They are independent regulatory facts. For more on the engineering interface compatibility, see our 4.0mm Snap ECG Electrodes Guide; for brand-level cross-reference, see OEM Compatible ECG Electrodes Guide.
Layer 4 — PMA (Premarket Approval)
PMA is the FDA's most rigorous review path, reserved for Class III devices that support or sustain human life or pose significant risk. Disposable ECG electrodes are Class II — they do not require PMA. Any supplier claiming "FDA PMA" for ECG electrodes is either confused or misrepresenting regulatory status.
Decoding a 510(k) K-Number and Reading the Summary
Short answer: A K-number is a six-digit identifier following the letter K (e.g., K252345). The first two digits encode the FDA fiscal year of receipt; the remaining digits are sequential. Every 510(k) clearance has a corresponding public 510(k) Summary or Statement on the FDA website, which any procurement officer can retrieve in under five minutes.
K-number anatomy
Example: K203456 was received in FDA fiscal year 2020 (1 Oct 2019 – 30 Sep 2020). A supplier whose only 510(k) is from before 2010 is operating under a clearance that may have technological assumptions older than current AAMI EC12 expectations — not necessarily disqualifying, but worth understanding.
How to look up a K-number on the FDA website
- Go to the FDA 510(k) Premarket Notification Database at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm.
- Enter the K-number in the "510(k) Number" field, or search by Applicant name or Product Code (DRX for disposable ECG electrodes).
- The result page lists: Decision Date, Applicant, Device Name, Product Code, and a link to the 510(k) Summary or Statement.
- Open the Summary PDF. Confirm: device description matches the SKU you are buying; Product Code is DRX; predicate device cited; intended use language matches the supplier's marketing.
- Cross-check the FDA "Establishment Registration & Device Listing" entry for the same applicant to confirm the manufacturing facility location matches the supplier's claimed location.
What to look for in the 510(k) Summary
| Section | What to verify |
|---|---|
| Device Trade Name | Matches the SKU on the supplier's quote |
| Common / Usual Name | "Electrode, electrocardiograph" or equivalent |
| Classification Name | Class II per 21 CFR 870.2360 |
| Product Code | DRX |
| Predicate Device(s) | K-number(s) cited as substantial equivalence basis |
| Indications for Use | Adult / pediatric / neonatal monitoring scope |
| Performance Standards | AAMI EC12 referenced; ISO 10993-5/-10 referenced |
| Sterility (if applicable) | EO sterilization with SAL = 10⁻⁶ stated for sterile-coded variants |
CE Marking Under MDR 2017/745 — Post-Transition Reality
Short answer: The EU Medical Device Regulation 2017/745 (MDR) replaced the prior Medical Device Directive (MDD) 93/42/EEC. The transition period for Class IIa devices (including disposable ECG electrodes) ended in May 2024. Any electrode marketed in the EU as of 2026 must hold valid MDR certification — old MDD certificates are no longer acceptable.
What MDR requires for ECG electrodes
- Classification: Class IIa under Rule 5 (Annex VIII), as a non-invasive device intended to channel or store substances/energy where the energy administered or removed is potentially hazardous (skin-contact monitoring devices).
- Notified Body involvement: Mandatory. A four-digit Notified Body number must appear adjacent to the CE mark on labeling and packaging.
- Technical documentation: Annex II (Technical Documentation) and Annex III (Technical Documentation on Post-Market Surveillance) must be available to competent authorities on request.
- EUDAMED registration: Manufacturer, Authorised Representative, and device data registered in the European Database on Medical Devices.
- EU Authorised Representative (EC REP): Manufacturers established outside the EU must designate an EC REP whose name and address appear on the labeling.
- Person Responsible for Regulatory Compliance (PRRC): The manufacturer must designate a qualified PRRC; for non-EU manufacturers, the EC REP must designate one as well.
- Unique Device Identification (UDI): Mandatory machine-readable UDI on packaging (Class IIa Basic UDI-DI requirement).
- Post-Market Surveillance Plan (PMS) and Periodic Safety Update Report (PSUR): Required and updated at intervals defined by the Notified Body.
How to verify a CE Marking
- Check the labeling and packaging for the CE mark followed by a four-digit Notified Body number (e.g., "CE 0123"). The number identifies the Notified Body that issued the certificate.
- Verify the Notified Body's authorization scope at the EU NANDO Database (ec.europa.eu/growth/tools-databases/nando). Confirm the Notified Body is designated for Regulation 2017/745 and for Class IIa monitoring devices.
- Request the full CE certificate PDF from the supplier — including all scope pages. Verify validity date (MDR certificates have a maximum 5-year validity).
- Verify the EC REP information appears on the certificate and on the product labeling.
- Cross-check the manufacturer and device entry in EUDAMED if accessible to your role.
The MDD-vs-MDR transition pitfall. Some suppliers continue to circulate old MDD-era certificates that are no longer valid for new EU sales as of May 2024. A genuine MDR certificate explicitly references "Regulation (EU) 2017/745" — not "Directive 93/42/EEC." If a supplier shows you a certificate that cites only the older Directive, the certificate cannot legally support new EU market entry in 2026.
ISO 13485 Verification: Beyond the Certificate Logo
Short answer: ISO 13485:2016 is the medical-device-specific quality management standard. It is not interchangeable with ISO 9001 (which is generic), and the certificate's value depends entirely on whether the issuing certification body is itself accredited under the IAF MLA (International Accreditation Forum Multilateral Recognition Arrangement).
Three-step ISO 13485 verification
- Verify the certificate scope. The scope page must explicitly include "ECG electrodes," "disposable ECG electrodes," "biopotential electrodes," or equivalent language. Generic scope language ("medical devices") is insufficient — it does not tell you whether ECG electrode manufacturing is actually within the audited operation.
- Verify the issuing certification body. Recognized bodies include BSI, TÜV SÜD, TÜV Rheinland, DEKRA, DNV, SGS, Intertek, and equivalents. The certification body must itself be accredited by an Accreditation Body that is a signatory to the IAF MLA — which provides international recognition. Look up the certification body in the IAF MLA Signatory list at iaf.nu.
- Verify the certificate is current and valid. Use the certification body's online verifier (most major bodies maintain a free public certificate-lookup tool). Confirm the issue date, expiration date (typically 3-year cycle with annual surveillance audits), and that the certificate is not in suspension or withdrawn status.
Key red flags in ISO 13485 documentation
ISO 9001 is a generic quality management standard. It does not include the design-control, sterilization-validation, biocompatibility-evaluation, lot-traceability, or post-market-surveillance requirements that govern medical device manufacturing. For Class II skin-contact devices like ECG electrodes, ISO 9001-only is a disqualifying signal.
If the issuing body is not a signatory member of the IAF Multilateral Recognition Arrangement, the certificate may not be recognized internationally — meaning customs, accreditation auditors, and other regulatory authorities may not accept it as valid evidence of compliance.
Suppliers showing only the front page of an ISO 13485 certificate while withholding the scope page are hiding what the certificate actually covers. The scope page must be reviewed before accepting the certification as evidence of ECG electrode manufacturing compliance.
An ISO 13485 certificate within 60 days of expiration without documented renewal in progress is a red flag. Surveillance audits and recertification are predictable events; failure to renew on schedule indicates either organizational dysfunction or audit-finding remediation issues.
AAMI EC12: How to Read the Performance Test Report
Short answer: AAMI EC12 (formally ANSI/AAMI EC12:2000(R)2020) is the U.S. performance standard for disposable ECG electrodes. It defines five electrical-performance parameters that determine signal quality and downstream false-alarm rate. Compliance is the regulatory floor for FDA 510(k); margin above the floor is what predicts clinical performance.
The five EC12 parameters and what they mean
| Parameter | EC12 limit | What it predicts clinically | MedLinket tested |
|---|---|---|---|
| AC impedance, average (10 Hz) | ≤ 2,000 Ω | Baseline signal quality; lower = less drift artifact | 109 Ω |
| AC impedance, single piece maximum | ≤ 3,000 Ω | Inter-piece consistency; tighter = lower false-alarm variance | 120 Ω |
| DC offset voltage | ≤ 100 mV | Polarization drift; lower = better long-wear stability | 4.11 mV |
| Bias current tolerance | ≤ 100 mV offset shift under bias | Stability against monitor bias currents | ≤ 5.1 mV |
| Combined offset instability & noise | ≤ 150 μV peak-to-peak | Signal-to-noise ratio; lower = fewer false arrhythmia triggers | 49.5 μV |
EC12 also specifies defibrillation overload recovery (the electrode must recover signal-quality baseline within a defined time after a defibrillation pulse) and simulated patient testing protocols.
These are pass/fail tests rather than continuous parameters; a quality manufacturer will document them but they do not differentiate suppliers in the same way the five core parameters do.
What a real EC12 test report looks like
A genuine third-party AAMI EC12 test report includes:
- Test laboratory identification — name, accreditation status (ideally GLP or ISO/IEC 17025), and signatory.
- Test article description — exact SKU, lot number, manufacturing date.
- Sample size — typically 12 to 24 electrodes per parameter; smaller samples indicate weaker statistical confidence.
- Numerical values for each parameter — not just "compliant" or "passed." Mean, standard deviation, minimum, maximum.
- Test methodology reference — citation to the specific EC12 section number for each measurement.
- Date and signature — recent (within the past lot's production window for lot-level reports).
Pass/fail vs. numerical value. A supplier providing only "AAMI EC12 compliant" without numerical values is providing the regulatory floor without the differentiation. Two electrodes can both "pass" EC12 with AC impedance of 1,800 Ω and 109 Ω — but the second produces a measurably lower clinical false-alarm rate. Always request the numerical values; suppliers that refuse are either hiding marginal performance or have not actually tested at the lot level. For the clinical-impact analysis of EC12 margins, see our companion article ECG Electrode Design and Alarm Fatigue.
ISO 10993 Biocompatibility for 24–48h Skin Contact
Short answer: Disposable ECG electrodes are categorized under ISO 10993-1 as "surface-contacting devices, intact skin, prolonged contact (greater than 24h to 30 days)". This category requires three biocompatibility test domains at minimum: cytotoxicity (-5), skin sensitization (-10), and skin irritation (the latter increasingly addressed under -23 since the 2021 ISO 10993-23 introduction).
The three required ISO 10993 sub-parts
Tests whether the electrode's adhesive and gel formulations release substances that kill cultured cells (typically L929 mouse fibroblasts) under controlled extraction. The test produces a cytotoxicity grade (0–4); for medical-device acceptance, the grade should be ≤ 2.
What to verify: The "test article" description must reference the actual adhesive and gel formulation in the product you are buying — not a generic family. Reports referring to a "representative sample" without naming the specific formulation are inadequate for procurement decisions.
Historically the primary skin-contact test, using guinea-pig maximization or Buehler test, or more recently in-chemico/in-vitro alternatives (DPRA, KeratinoSens, h-CLAT) following the 2021 ISO 10993-23 split.
What to verify: Test method (modern alternatives are increasingly accepted), result negative for sensitization, and that the test article matches the actual product.
Introduced in 2021 to consolidate skin-irritation testing previously distributed across -10. Uses reconstructed human epidermis (RhE) models or, where unavailable, animal-based methods. Important: any "ISO 10993-10 only" report dated after 2022 is likely missing the irritation domain that ISO 10993-23 now formally covers.
What to verify: Test article matches; result is "non-irritant"; report is post-2021 to reflect the updated standard.
For sterile-packaged electrodes (-S- coded), ISO 10993-7 (residual ethylene oxide) is required to verify post-sterilization residual EO is below 4 μg/cm² for prolonged-contact devices. For pediatric/neonatal applications, additional weight-of-evidence on chemical characterization (ISO 10993-18) may be required by FDA reviewers.
Why this matters disproportionately for ECG electrodes
The skin's three barrier systems — microbial (resident flora maintaining slightly acidic pH 4.5–6.5), chemical (the lipid acid mantle composed of ceramides, free fatty acids, and cholesterol), and physical (the 12–20 layer stratum corneum brick-and-mortar structure) — are simultaneously challenged during 24- to 48-hour electrode wear: the microbial layer by sweat occlusion, the chemical layer by adhesive components, and the physical layer by edge friction from lead-wire forces. ISO 10993-10 and -23 testing is the regulatory anchor that validates the adhesive design will not destabilize these barriers within the intended wear time.
Suppliers claiming "hypoallergenic" or "low allergy" without ISO 10993-10/-23 third-party reports on the actual production formulation are making marketing claims without substantiation. For the deeper material-science background, see our Low-Allergy ECG Electrodes Explained article.
Sterile vs Non-Sterile: The Regulatory Difference Most Buyers Miss
Short answer: Sterile ECG electrodes (typically marked with an "-S-" suffix in MedLinket's coding) are subject to additional regulatory standards beyond the non-sterile equivalent — specifically EO sterilization validation under EN ISO 11135, sterile barrier system validation under ISO 11607-1/-2, and residual EO testing under ISO 10993-7. The procurement implication is that sterile and non-sterile variants of the "same" electrode are regulatorily distinct products with separate documentation packs.
What sterile-coded electrodes legally require
| Standard | What it covers | What to request |
|---|---|---|
| EN ISO 11135 | Ethylene oxide sterilization process validation | Process validation report; cycle parameters (temp, humidity, EO concentration, dwell time) |
| ISO 11607-1 | Sterile barrier system requirements | Pouch material specification; seal integrity testing (ASTM F1929 dye penetration, F88 peel strength) |
| ISO 11607-2 | Sterile barrier system validation | Packaging validation report; aging study; transit testing |
| ISO 11737-1 | Bioburden determination | Pre-sterilization bioburden testing per lot or per validation period |
| ISO 10993-7 | Residual ethylene oxide testing | Residual EO ≤ 4 μg/cm² (prolonged-contact device limit), residual ECH ≤ 9 μg/cm² |
| EN 868 series | Specific sterile packaging materials | Pouch material certification (e.g., medical-grade Tyvek, Mylar, paper-film laminate) |
SAL = 10⁻⁶ — the medical sterility benchmark
Sterility Assurance Level (SAL) of 10⁻⁶ is the standard for terminally sterilized medical devices marketed in the U.S., EU, and most other regulated markets. SAL = 10⁻⁶ means the probability of a single viable microorganism on a sterilized device is one in one million. For ECG electrodes specifically, EO sterilization is preferred over gamma irradiation because the conductive gel and pressure-sensitive adhesive are heat- and radiation-sensitive; gamma irradiation can cause crosslinking changes that affect both gel ion conductivity and adhesive peel-force performance.
7-Step Verification Protocol (30 Minutes Per Supplier)
Short answer: A supplier compliance verification can be completed in 15 to 30 minutes using only public databases and the supplier's certificate documents. The protocol below is the practical verification sequence used in tender review and accreditation audits.
- Request original certificate PDFs (not screenshots, not first-page only). Specifically request: 510(k) clearance letter, full CE certificate including all scope pages, ISO 13485 certificate including scope page, ISO 10993-5/-10/-23 third-party test reports, AAMI EC12 lot-level test report (most recent three lots), MDSAP audit summary if claimed.
-
Verify FDA 510(k) at the FDA database. Search by K-number at
accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Confirm: applicant name matches supplier; Product Code = DRX; clearance date; Decision = "SE" (Substantially Equivalent); device description matches the SKU on the supplier's quote. -
Verify CE Notified Body at NANDO Database. Look up the four-digit number from the CE certificate at
ec.europa.eu/growth/tools-databases/nando/. Confirm: Notified Body designated under Regulation 2017/745 (not the older Directive 93/42/EEC); designation scope includes Class IIa electrocardiograph electrodes; designation status is current. -
Verify ISO 13485 certification body at IAF MLA. Confirm the issuing body is an IAF MLA signatory at
iaf.nu. Use the certification body's own online verifier to confirm the certificate number is current (not expired, suspended, or withdrawn). Confirm the scope page explicitly references ECG electrodes. - Cross-check legal entity, manufacturing address, and shipping address. The legal entity on the FDA listing, the certificate, the quotation, and the proforma invoice should all match. Discrepancies indicate trading-company intermediaries that may not be the actual manufacturer.
- Verify ISO 10993 test article matches actual product. Read the "test article" or "sample description" section of each ISO 10993-5, -10, and -23 report. The adhesive type, gel formulation, and physical configuration must match the SKU you are buying. Generic family reports without specific SKU identification are inadequate for procurement decisions on Class II skin-contact devices.
- Request lot-level AAMI EC12 test report and verify numerical values. The most recent three production lots should be available within the supplier's quality system. Verify all five EC12 parameters are reported as numerical values (not "compliant" or "passed"). Inter-lot consistency is a quality signal — wide variance with all values within EC12 limits indicates marginal manufacturing.
Region-by-Region "Must Have" vs "Nice to Have"
Short answer: Regulatory requirements vary by destination market. The minimum required documentation depends on where the electrodes will ultimately be used; "nice to have" certifications smooth customs clearance, accreditation audits, and downstream re-registration in adjacent markets.
| Destination market | Mandatory | Strongly preferred |
|---|---|---|
| United States | FDA 510(k) (Product Code DRX); FDA Establishment Registration; FDA Device Listing; ISO 13485 | MDSAP; ISO 10993-5/-10/-23; AAMI EC12 lot-level reports |
| European Union | CE Marking under MDR 2017/745 with Notified Body number; EC REP designation; EUDAMED registration; ISO 13485 | MDSAP; ISO 10993-5/-10/-23; UDI assignment evidence |
| United Kingdom (post-Brexit) | UKCA marking (or recognized CE mark per current MHRA transition rules); UK Responsible Person; ISO 13485 | MDSAP; ISO 10993; FDA 510(k) (often referenced in tenders) |
| Canada | Health Canada Medical Device License; MDSAP (mandatory for Class II since 2019); ISO 13485 | FDA 510(k); CE Marking |
| Brazil | ANVISA registration (Resolution RDC 751/2022); BPF (Brazilian GMP); ISO 13485 + Brazilian-recognized issuer | MDSAP (recognized for ANVISA submissions); INMETRO conformity assessment |
| Australia | TGA inclusion in ARTG (Australian Register of Therapeutic Goods); MDSAP recognized | FDA 510(k); CE Marking; MDSAP |
| Japan | PMDA Marketing Approval / Notification (Class II Tokutei Hoshu Iryo Kiki); J-MDR | MDSAP recognized |
| China | NMPA Class II registration certificate; domestic GMP; ISO 13485 (recognized) | MDSAP; FDA 510(k) |
Practical implication for international distributors: Sourcing from a manufacturer with simultaneous FDA 510(k) + CE MDR + MDSAP + NMPA + ISO 13485 + ISO 10993 coverage substantially reduces re-registration friction across multiple destination markets. MDSAP in particular consolidates audits across FDA, Health Canada, ANVISA, TGA, and PMDA — a single audit with multi-country recognition is an underutilized procurement leverage point.
Frequently Asked Questions
Q1: Are ECG electrodes "FDA approved"?
Technically no. The FDA does not "approve" Class II devices — it clears them through 510(k) Premarket Notification. "FDA approved" is the term used for Class III devices that go through PMA review. Disposable ECG electrodes are Class II under 21 CFR 870.2360 (Product Code DRX) and are FDA cleared via 510(k). Suppliers using "FDA approved" loosely are either uninformed about the regulatory distinction or deliberately blurring it.
Q2: Do "compatible" replacement ECG electrodes need their own FDA 510(k)?
Yes. Even when marketed as "compatible with Philips" or "compatible with GE," the manufacturer must hold its own 510(k) clearance demonstrating substantial equivalence to a predicate device. Compatibility describes the physical/electrical interface; 510(k) describes the safety and performance equivalence. They are independent regulatory facts. Compatibility marketing without an underlying 510(k) is illegal U.S. marketing of an unauthorized Class II device.
Q3: Is "FDA Registered" the same as "FDA Cleared"?
No. FDA Establishment Registration (Form FDA 2891) is an annual facility listing that confirms the manufacturer's facility exists and is registered with FDA. FDA Device Listing (Form FDA 2892) identifies which products that facility makes. Neither is a clearance. FDA 510(k) Clearance is the actual review of the specific product's substantial equivalence and is the only one of the three that authorizes U.S. marketing for a Class II device.
Q4: What is a K-number and how do I look one up?
A K-number is a six-digit identifier following the letter K (e.g., K252345) assigned to each 510(k) submission. The first two digits encode the FDA fiscal year of receipt; the remaining digits are sequential. Look up any K-number at the FDA 510(k) Premarket Notification Database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm). The result page links to the 510(k) Summary, which describes the device, predicate, indications for use, and performance standards referenced.
Q5: Is ISO 9001 enough for an ECG electrode supplier?
No. ISO 9001 is a generic quality management standard for any industry. For medical-device manufacturing — including disposable ECG electrodes as Class II skin-contact devices — the standard is ISO 13485, which adds requirements for design control, sterilization-process validation, biocompatibility, traceability, adverse-event handling, and CAPA (corrective and preventive action). ISO 9001-only is a disqualifying signal regardless of how impressive other documentation looks.
Q6: Are old MDD CE certificates still valid in the EU in 2026?
For Class IIa devices including disposable ECG electrodes, the MDR transition period ended in May 2024. Old MDD-era CE certificates (citing Directive 93/42/EEC) cannot legally support new EU market entry as of 2026. Any electrode marketed in the EU must hold a valid MDR certificate — citing Regulation (EU) 2017/745 — issued by a Notified Body designated under MDR. Always verify the CE certificate cites the Regulation, not the older Directive.
Q7: How long does it take to verify a supplier's compliance?
Using the 7-step protocol with public databases, basic verification takes 15 to 30 minutes per supplier: 510(k) lookup at FDA database (5 minutes), Notified Body verification at NANDO (5 minutes), ISO 13485 issuer verification at IAF MLA (5 minutes), and document cross-check (10 minutes). A complete supplier audit including AAMI EC12 third-party retest and ISO 10993 report review extends to 1–2 weeks.
Q8: What does ISO 10993-10 actually prove?
ISO 10993-10 is the international standard for skin sensitization testing on the actual electrode adhesive and gel materials. A negative result means the test article did not cause an allergic-type immune response in the standardized model. Combined with ISO 10993-23 (skin irritation, introduced 2021) and ISO 10993-5 (cytotoxicity), it forms the regulatory basis for any "hypoallergenic" or "low-allergy" claim. Without these reports — specifically on the actual production formulation — such marketing claims have no substantiation.
Q9: Are MDSAP-certified manufacturers automatically FDA cleared?
No. MDSAP is a quality management system audit program — it is not a product clearance. A manufacturer can hold MDSAP certification (audited under FDA, Health Canada, ANVISA, TGA, and PMDA) and still need separate 510(k) clearance for each product family marketed in the U.S. MDSAP and 510(k) are independent regulatory mechanisms; both are required for U.S. marketing. The strength of MDSAP is that it consolidates the QMS audit across five jurisdictions.
Q10: What's the simplest test that disqualifies an ECG electrode supplier?
If a supplier cannot, on request, produce: (a) a verifiable K-number for U.S. sales, (b) a CE certificate citing Regulation 2017/745 with a NANDO-verifiable Notified Body for EU sales, (c) an ISO 13485 scope page explicitly mentioning ECG electrodes from an IAF MLA-recognized issuer, and (d) recent ISO 10993-5 / -10 / -23 third-party reports on the actual production formulation — the supplier is not qualified for Class II skin-contact device procurement, regardless of price or delivery terms.
How MedLinket Stands Up to the Verification Protocol
For procurement, distributor, and OEM teams using this verification protocol — here is how MedLinket's documentation answers each layer of the framework. The same evidence we encourage you to demand from any supplier.
| Layer | MedLinket evidence |
|---|---|
| FDA 510(k) clearances | 19 active 510(k) clearances under Product Code DRX and related codes |
| FDA Establishment Registration + Device Listing | Active registration; full device listing on file |
| CE Marking under MDR 2017/745 | 48 Class II CE certifications under MDR with Notified Body designation; 16 Class I certifications |
| UK MHRA | 11 Class II + 21 Class I registrations |
| ISO 13485:2016 | Certified, scope explicitly covers ECG electrode manufacturing; ISO 9001:2015 also held |
| MDSAP | Certified; covers FDA / Health Canada / ANVISA / TGA / PMDA |
| NMPA (China) | 33 Class II registrations + 15 Class I filings |
| Brazil ANVISA | 34 product registrations (BPF + RDC 751/2022) |
| Australia TGA | 14 ARTG inclusions |
| Japan PMDA | 6 product approvals/notifications |
| ISO 10993-5/-10/-23 | Full third-party biocompatibility test reports for V0014 / V0015 series adhesive and gel formulations |
| AAMI EC12 lot-level performance | AC impedance 109 Ω · DC offset 4.11 mV · combined offset instability and noise 49.5 μV (~18×, ~24×, ~3× margins versus EC12 limits) |
| EN ISO 11135 EO sterilization | Validated for sterile-coded (-S-) variants; SAL = 10⁻⁶ |
| Manufacturing facilities | Three self-owned facilities (Shenzhen HQ + Shaoguan + Indonesia); passed on-site audits by NMPA, FDA, ANVISA; annual audits by Mindray, Philips, and other major OEM partners |
All certificates, K-numbers, Notified Body numbers, and lot-level test reports are available to qualified buyers via the channels listed below.
Request the Complete Compliance Documentation Pack
Receive the full verification pack: scanned FDA 510(k) clearance letters with K-numbers · CE certificate including all scope pages · ISO 13485 certificate including scope page · MDSAP audit summary · NMPA / ANVISA / TGA / PMDA / MHRA registration scans · ISO 10993-5/-10/-23 third-party biocompatibility reports · AAMI EC12 lot-level test reports for the most recent three production lots · EN ISO 11135 EO sterilization validation for the sterile (-S-) coded series.
📧 Email shopify@medlinket.com with your company name, role, destination market, and SKU set of interest.
💬 WhatsApp our regulatory affairs team: +852 6467 3105
📦 Request Compliance Pack → Browse Disposable ECG ElectrodesReferences & Standards / Sources
U.S. Federal Regulations
- 21 CFR Part 807, Subpart E — Premarket Notification (510(k)) procedures.
- 21 CFR 870.2360 — "Electrode, electrocardiograph" classification under cardiovascular devices; Product Code DRX.
- 21 CFR Part 820 — Quality System Regulation (QSR) for U.S. medical-device manufacturing.
- U.S. FDA 510(k) Premarket Notification Database — public lookup at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm.
- U.S. FDA Establishment Registration & Device Listing Database — public lookup at accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm.
EU Regulations
- Regulation (EU) 2017/745 (MDR) — Medical Device Regulation; Class IIa requirements applicable to disposable ECG electrodes.
- EU NANDO Database — Notified Body designation lookup at ec.europa.eu/growth/tools-databases/nando/.
- EUDAMED — European Database on Medical Devices (manufacturer, AR, and device registration).
International Quality & Performance Standards
- ISO 13485:2016 — Medical devices — Quality management systems — Requirements for regulatory purposes.
- ANSI/AAMI EC12:2000(R)2020 — Disposable ECG Electrodes (electrical performance specification).
- ANSI/AAMI EC53 — ECG Cables and Leadwires (referenced for connector and lead-wire interface specifications).
- IEC 60601-1-8 — General requirements, tests, and guidance for alarm systems in medical electrical equipment.
- IEC 60601-2-27 — Particular requirements for electrocardiographic monitoring equipment.
Biocompatibility Standards
- ISO 10993-1 — Biological evaluation of medical devices — Evaluation and testing within a risk management process.
- ISO 10993-5 — Tests for in-vitro cytotoxicity.
- ISO 10993-10 — Tests for skin sensitization.
- ISO 10993-23 — Tests for skin irritation (introduced 2021).
- ISO 10993-7 — Ethylene oxide sterilization residuals.
- ISO 10993-18 — Chemical characterization of medical-device materials within a risk-management process.
Sterilization & Packaging Standards
- EN ISO 11135 — Sterilization of health-care products — Ethylene oxide.
- ISO 11607-1 — Packaging for terminally sterilized medical devices — Requirements for materials, sterile barrier systems, and packaging systems.
- ISO 11607-2 — Packaging for terminally sterilized medical devices — Validation requirements for forming, sealing, and assembly processes.
- ISO 11737-1 — Sterilization of health-care products — Microbiological methods — Determination of a population of microorganisms on products.
Audit & Recognition Programs
- MDSAP — Medical Device Single Audit Program covering FDA, Health Canada, ANVISA (Brazil), TGA (Australia), and PMDA (Japan).
- IAF MLA — International Accreditation Forum Multilateral Recognition Arrangement; signatory list at iaf.nu.
Internal Product References
- MedLinket internal product specification documentation — V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) ECG electrode series; SKU codes, AAMI EC12 tested values, biocompatibility test articles, sterile barrier validation. Available on request via shopify@medlinket.com.
- MedLinket internal regulatory affairs documentation — full list of FDA 510(k) K-numbers, CE certificate Notified Body numbers, ISO 13485 certificate, MDSAP audit summary, and regional registrations across 120+ countries. Available to qualified buyers under NDA.
- Patent CN202120112524.5 — MedLinket eccentric (offset) ECG electrode structural design, granted utility model patent. Publicly searchable in CNIPA database. Part of the broader MedLinket IP portfolio: 45 utility-model patents, 8 invention patents, 26 design patents, 1 PCT international patent, 13 software copyrights.
Continue Reading
Related articles in the MedLinket ECG Electrodes Resource Hub:
- ECG Electrodes: The Complete Buyer's & Clinical Guide (2026) — the parent pillar covering structure, sizing, material, and clinical scenarios.
- How to Evaluate ECG Electrode Suppliers: 12 Must-Check Criteria — the broader supplier scoring framework that contextualizes these regulatory checks.
- OEM Compatible ECG Electrodes Guide — brand-by-brand cross-reference and substantial-equivalence detail for compatible electrodes.
- 4.0mm Snap ECG Electrodes Guide — engineering deep-dive on the connector specification.
- Low-Allergy ECG Electrodes Explained — ISO 10993-10/-23 evidence base for hypoallergenic claims.
- ECG Electrode Design and Alarm Fatigue — clinical impact of AAMI EC12 performance margins.
- Offset vs Center-Post ECG Electrodes — laboratory test data referenced in the supplier R&D evaluation criterion.
- ECG Electrodes by Patient Type — adult, pediatric, neonatal, and sensitive-skin selection.
- Disposable vs Reusable ECG Electrodes — total cost of ownership context.
- Sterile ECG Electrodes Clinical Guide — 9-scenario framework for sterile vs non-sterile selection.
- Bulk ECG Electrodes Procurement Guide — MOQ, TCO, 9 contract clauses for procurement.
- How ECG Electrodes Are Made — 6-layer structure, 12-step process, AAMI EC12 measured data.
About MedLinket
MedLinket (Shenzhen Med-link Electronics Tech Co., Ltd) has specialized in capturing and transmitting vital biological signals since 2004. Listed on the Chinese New Third Board (NEEQ: 833505) since 2015, MedLinket was the first Chinese listed company in the monitoring consumables sector. We hold 33 NMPA Class II registrations, 19 FDA 510(k) clearances, 48 CE Class II certifications under MDR 2017/745, ISO 13485:2016, ISO 9001:2015, and MDSAP certifications, plus 11 UK MHRA Class II, 34 Brazilian ANVISA, 14 Australian TGA, and 6 Japanese PMDA registrations.
Our intellectual-property portfolio includes 45 granted utility-model patents, 8 invention patents, 26 design patents, 1 PCT international patent, and 13 software copyrights — covering structural design, materials, algorithms, and external appearance.
The MedLinket V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) ECG electrode series — available in sterile (-S-) and non-sterile variants across six standard sizes from neonatal Φ25 mm to adult Holter 70.5 × 55 mm, including the patented eccentric (offset) thin-neck FPC structural design under utility-model patent CN202120112524.5 — supply 2,000+ hospitals across 120+ countries, including Royal Victoria Hospital (UK) and Institut Hospitalier Jacques Cartier (France); 14 countries record annual sales above USD 1 million. USD 5 million product-liability insurance per occurrence, with distributors named as additional insured on request.
Inquiry response within 1 hour; repair / quotation turnaround within 2 days; on-site audits by NMPA, FDA, and ANVISA passed; annual audits by Mindray, Philips, and other major OEM partners passed. Full compliance documentation available to qualified buyers via shopify@medlinket.com or WhatsApp +852 6467 3105.
⚠️ Regulatory & Procurement Disclaimer. This article is intended for procurement, regulatory affairs, and BMET education only. It is not legal advice and is not a substitute for consultation with qualified medical-device regulatory counsel in your destination market. Regulatory environments evolve continuously — verify the current text of all cited regulations (FDA 21 CFR Parts 807 and 820, EU MDR 2017/745, ISO 13485:2016, ISO 10993 series, AAMI EC12, EN ISO 11135, ISO 11607) directly with the issuing authority before using citations in formal tender, registration, or audit documents.
Standards revisions, transition deadlines, and certificate-renewal timelines change; the information above reflects the regulatory landscape as understood at the time of publication. Performance figures attributed to MedLinket are from internal product specification and laboratory test documentation; equivalence to other suppliers' products requires identical test method and standard reference. Always conduct local validation against your destination-market regulatory authority and follow institutional procurement policies.
This article is part of MedLinket's ECG Electrodes Resource Hub. Last reviewed by Regulatory Affairs Director, MedLinket Quality & Regulatory Team — May 11, 2026.
